Recent Events

2008 Beijing International Lymphoma Symposium

Beijing 2008 International Lymphoma Symposium

April 10 to April 12, Beijing Cancer Research Institute and Beijing University, Beijing, China

April 10, 2008 Morning I Section Chair: Dr. Shi, MD
8:30—8:40,Welcome from the President, Dr. You, & the Director of CSCO, Dr. Ma
8:40—9:25, Elaine Jaff, MD, NIH/NCI, USA, (Pathology and Biology of T-cell and NK-cell lymphoma)
9:25—10:10 , John Chan, MD, University of Nebraska Medical Center (Recent advance of gene expression profiling in lymphomas)
10:10—10:20, Tea and Coffee Break

April 10, 2008 Morning II Section Chair: Dr. Ke, MD
10:20—11:05, Issa F. Khouri, MD, MD Anderson Cancer Center (Management of lymphoma with stem cell transplantation)
11:05—11:50, Eric Hsi, MD, Cleveland Clinic (Classical Hodgkin lymphoma: Pathology and identification of prognostic markers).
11:50—12:20, Questions and Answers
12:30, Lunch and BreakMore.

April 10, 2008 Afternoon I Section Chair: Dr. Zhang, MD
14:00—14:45, John Pagel, MD, University of Washington School of Medicine (Update on clinical trial data on non-Hodgkin lymphomas).
14:45—15:15, Fan Zhou, MD, PhD, Southwestern Washington Medical Center (an update on flow cytometric study of indolent lymphomas).
15:15—16:00, Ken H. Young, MD, Ph.D, University of Wisconsin School of Medicine (Diffuse large B cell lymphoma: Combined gene expression profile and mutation analysis improves risk stratification and prognosis: An international collaborative study).
16:15—16:25, Tea and Coffee Break

April 10, 2008 Afternoon II Section Chair: Dr. Gao, MD
16:25—16:55, Kai Fu, MD, PhD, University of Nebraska Medical Center (Aggressive B-cell lymphoma: Molecular genetics and their correlation to targeted therapy).
16:55—17:25, Huang Qin, MD, PhD, City of Hope Hospital (Molecular and cytogenetic testing in lymphoma diagnosis).
17:25—17:55, Ye Gang, MD, Southwestern Washington Medical Center (Advances in the management of refractory or relapsed high grade non-Hodgkin lymphomas).
17:55—18:05, Questions and Answers.
18:30, Dinner and Performance.

April 11, 2008 Morning I Section Chair: Dr. Lin, MD
8:30—9:00, Dr. Zhou, MD, Beijing Friendship Hospital (Differences of lymphoma classification between Western and Eastern Countries).
9:00—9:30, Dr. Yong, MD, Beijing Cancer Hospital (Treatment experience of NK/T-cell lymphomas).
9:30—10:00, Dr. Shi, MD, Chinese Academy of Cancer Hospital (The role of autologous SCT in lymphomas).
10:00—10:15, Tea and Coffee Break.

April 11, 2008 Morning II Section Chair: Dr. Zhou, MD
10:15—10:45, Dr. Lin, MD, Zhongshan University Cancer Hospital (Peripheral T-cell lymphomas).
10:45—11:15, Dr. Ma, MD, Harbin Hematology Institute (Lymphoma and autoimmune-related pancytopenia).
11:15—11:45, Dr. Zhu, MD Fudan Cancer Hospital (Biphenotypic or composite lymphomas)
11:45—12, Questions and Answers
12:30, Lunch and Break

April 11, 2008 Afternoon I Section Chair: Dr. Shen, MD
14:00—14:30, Dr. Gao, MD Peking University 3rd Hospital (Detection of ALK gene abnormality by FISH in ALCL)
14:30—15:00, Dr. Ke, MD Peking University 3rd Hospital ( Target therapies for lymphomas)
15:00—15:30, Dr. Zhang, MD Beijing Children’ Hospital (Pediatric lymphomas in China)
15:30—15:40, Tea and Coffee Break

April 11, 2008 Afternoon II Section Chair: Dr. Zhang, MD
15:40—16:05, Dr. Shen, MD Shanghai Hematology Institute (Comparison of diagnostic and treatment strategies between ALL and LBL)
16:05—16:30, Dr. Zhang, MD, Shanxi Provincial Cancer Hospital (Refractory lymphomas, NHL/HL)
16:30—17:30, Case Discussion, Questions and Answers
18:00—19:00, Dinner
19:00—20:30, Meet with Experts (Locations: Hematology- Auditorium; Hematopathology- Conference Room).

April 12, 2008 Morning I Section Chair: Dr. Zhang, MD
8:30—8:50, Qinglong Hu, MD, PhD, Creighton University Medical Center (Fine needle biopsy and flow cytometry in Diagnosis of Lymphomas: application and limitation).
8:50—9:10, Dr. Li, MD, Beijing Cancer Hospital (Role of needle aspiration in lymphoma diagnosis).
9:10—9:40, Dr. Zhang, MD, The 307 Military Hospital (The role of PET-CT in the diagnosis/evaluation of treatment effect/prognosis of lymphomas).
9:40—10:10, Dr. Chen, MD, PhD, Beijing Chaoyang Hospital (First-line treatments in multiple myeloma)
10:10—10:20, Tea and Coffee Break

April 12, 2008 Morning II Section Chair: Dr. Yong, MD
10:20—10:50, Ming-Qing Du, MD, PhD, University of Cambridge (KSHV and lymphoproliferative disorders)
10:50—11:50, Case Discussion.
11:50—12:10, Questions and Answers.
12:30, Lunch and Break.

April 12, 2008 Afternoon I Section Chair: Dr. Shen, MD
14:00—14:25, Dr. Huang, MD, Peking University People’s Hospital (Post-transplant lymphoproliferative disorders).
14:25—14:50, Dr. Qiu, MD, Tianjin Hematology Institute (Diagnosis and treatment advances of lymphomas with bone marrow involvement).
14:50—15:15, Dr. Li, MD, Chinese Academy of Cancer Hospital (Role of radiotherapy in early-staged HL).
15:15—15:25, Tea and Coffee Break.

April 12, 2008 Afternoon II Section Chair: Dr. Shen, MD
15:25—15:50, Dr. Wang, MD, Beijing Union Hospital (Diagnosis and treatment advances of CNS lymphoma).
15:50—16:15, Dr. Zhu, MD, Beijing Cancer Hospital (Clinical trials’ experiences of lymphomas treatment in China).
16:15—16:40, Dr. Huang, MD, Zhongshan University Cancer Hospital (Clinical trial:CEOP..90 regimen in lymphomas).
16:40—17:10, Discussion, Questions, and Answers.

© 2008 hematopathologist.com. (RSS)